In this study we provide evidence that co-delivery of GM-CSF with an H1N1 influenza DNA vaccine using a disposable PMED clinical device substantially increased DNA vaccine potency for induction of both neutralizing antibody and T cell responses in the highly relevant preclinical nonhuman primate model. The gene discussed is CSF2; the disease is swine influenza.